Teleflex (NYSE:TFX) Reaches New 52-Week Low – Should You Sell?

Teleflex Incorporated (NYSE:TFX) reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $165.62 and last traded at $169.33, with a volume of 537805 shares. The stock had previously closed at $167.43.

Analysts Set New Price Targets

A number of analysts have recently issued reports on TFX shares. Royal Bank of Canada cut their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Mizuho cut their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Finally, Truist Financial cut their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Trading Up 1.1 %

The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock has a market capitalization of $7.86 billion, a P/E ratio of 33.66, a price-to-earnings-growth ratio of 1.65 and a beta of 1.16. The firm’s fifty day simple moving average is $177.75 and its 200 day simple moving average is $208.74.

Institutional Investors Weigh In On Teleflex

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. T. Rowe Price Investment Management Inc. grew its holdings in shares of Teleflex by 4.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company’s stock valued at $1,098,693,000 after purchasing an additional 261,279 shares during the last quarter. Janus Henderson Group PLC grew its holdings in shares of Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after purchasing an additional 147,147 shares during the last quarter. State Street Corp grew its holdings in shares of Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock valued at $508,757,000 after purchasing an additional 21,291 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Teleflex by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company’s stock valued at $202,161,000 after purchasing an additional 8,307 shares during the last quarter. Finally, Cooke & Bieler LP grew its holdings in shares of Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after purchasing an additional 195,150 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.